CoChat

Effectiveness of Dienogest for Treatment of Recurrent Endometriosis: Multicenter Data

Open access

The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.

Abstract

This study aimed to assess whether dienogest (DNG) is also effective in patients with recurrent endometriosis based on multicenter data of 121 women who were clinically diagnosed as having recurrent endometriosis and treated for more than 24 weeks with DNG (2 mg daily). We evaluated the changes in endometriosis-associated pain scores (visual analog scale [VAS]), serum cancer antigen 125 (CA-125) levels, and endometrioma sizes following DNG medication in these women along with adverse events associated with DNG medication. The mean duration of DNG treatment was 57.80 (24.08) weeks, and during continuation of DNG, the mean VAS score was 5.03 (1.73) at baseline and significantly decreased to 2.46 (1.32) at 24 weeks after taking DNG. In subgroup analysis, the trend of pain-related symptoms was compared between the symptom-only recurrence group and the recurrent endometrioma group. In both groups, the pain scores decreased significantly during the first 24 weeks but remained relatively unchanged thereafter. Moreover, the size of recurrent endometriomas and CA-125 levels also decreased significantly compared to baseline. The mean size of recurrent endometriomas was 3.77 (1.59) cm in diameter and decreased to 2.74 (1.53) cm after 24 weeks of DNG treatment ( P for trend < .001). The mean CA-125 level was 80.04 U/mL at baseline and significantly decreased to 33.11 U/mL after taking DNG for 24 weeks and lasted until 72 weeks ( P for trend = .0288). Overall, 51 (42.15%) patients reporte…

Overview

Integrity signals

Registry

Crossref · 10.1177/1933719118779733

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 45 references

Research works printed but not linked: 1

  1. DeLoach L, Higgins M, Caplan A, Stiff J. The visual analog scale in the immediate postoperative period. Anesth Analg. 1998; 86(1):102–106.

Cited by

See all 46

Metadata

Authors
Lee, J. H., Song, J. Y., Yi, K. W., Lee, S. R., Lee, D.-Y., Shin, J.-H., Cho, S., Seo, S. K., & Kim, S. H.
Affiliations
  • Yonsei University (KR)
  • The Catholic University of Korea Uijeongbu St. Mary's Hospital (KR)
  • Korea University (KR)
  • Ewha Womans University (KR)
  • Samsung Medical Center (KR)
  • Asan Medical Center (KR)
Corresponding author
  • Seo, Seok Kyo
  • Kim, Sung Hoon
Venue
Reproductive Sciences
Published
2018-10
Volume
25
Issue
10
Pages
1515-1522
ISSN
  • 1933-7191 (ISSN-L)
  • 1933-7205
OpenAlex
W2806443010
Cited by
44
References
44
Citations by year
2026: 5 · 2025: 7 · 2024: 8 · 2023: 5 · 2022: 4 · 2021: 5 · 2020: 4 · 2019: 4 · 2018: 2
FWCI
4.02
Type
journal article
Language
en
Open access
Licence
Locations
  • Reproductive Sciences (publishedVersion)
  • PubMed (publishedVersion)
  • YUHSpace (Yonsei University Medical Library) (submittedVersion, cc-by-nc-nd)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
  • Health Sciences › Medicine › Obstetrics and Gynecology › Ectopic Pregnancy Diagnosis and Management
  • Health Sciences › Medicine › Obstetrics and Gynecology › Gynecological conditions and treatments
Keywords
dienogest, recurrent endometriosis, endometrioma size, CA125, endometriosis-associated pain, irregular bleeding, adverse events
MeSH terms
Adult, Amenorrhea, Endometriosis, Female, Hormone Antagonists, Humans, Nandrolone, Pain, Pain Measurement, Recurrence, Retrospective Studies, Multicenter Studies as Topic, Treatment Outcome, CA-125 Antigen

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effectiveness of Dienogest for Treatment of Recurrent Endometriosis: Multicenter Data. https://app.cochat.ai/papers/10.1177/1933719118779733
The paper
Lee, J. H., Song, J. Y., Yi, K. W., Lee, S. R., Lee, D.-Y., Shin, J.-H., Cho, S., Seo, S. K., & Kim, S. H. (2018). Effectiveness of Dienogest for Treatment of Recurrent Endometriosis: Multicenter Data. Reproductive Sciences. https://doi.org/10.1177/1933719118779733

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.